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In this issue of Neuron, Tang et al. (2014) explore the relationship between developmental dendritic pruning,
elevated mTORC1 signaling, macroautophagy, and autism spectrum disorder. The study provides valuable
new insight into mTORC1-dependent cellular dysfunction and neurodevelopmental disorders.Autism spectrum disorder (ASD) currently
affects up to 1 in 68 children worldwide
(http://www.cdc.gov/mmwr/preview/mm
wrhtml/ss6302a1.htm?s_cid=ss6302a1_
w). Although monogenic disorders with a
high incidence of ASD and mutations in
genes that increase the risk for ASD
have been identified, the genetic causes
of ASD are largely unknown, highlighting
the crucial need to determine whether
there is convergence of molecular sig-
naling among ASD patients to provide
for novel therapeutic targets. Dysregu-
lated protein synthesis has been impli-
cated as a potential common converging
mechanism in ASD (Santini et al., 2013),
but the involvement of other mechanisms
for proteostatic regulation such as deg-
radation and autophagy has not been
well characterized. Macroautophagy is
the process of breaking down of unused
proteins and damaged cellular organelles,
and although implicated inmultiple neuro-
degenerative disorders (Fecto et al.,
2014), it has not been studied widely in
either neurodevelopment or in ASD.
Tang and colleagues (2014), uncover a
novel mechanistic contribution of macro-
autophagy (autophagy) to ASD, unveiling
a new potential avenue for investigation,
and potentially therapeutic targets.
Tang et al. (2014) found that dendritic
spine density in human ASD and control
brains was similar earlier in life (ages 2–
9), which then declined in control brains
(ages 13–20) but not in ASD brains, sug-
gesting that there may be disruption in
synaptic pruning in individuals with ASD.
The increase in spine density in the ASD
brains was correlated with elevated phos-
phorylation of mammalian target of rapa-
mycin (mTOR) and one of its downstream
effectors, ribosomal protein S6, which has994 Neuron 83, September 3, 2014 ª2014 Elbeen observed previously in mouse
models and humans with monogenic
syndromes with high incidence of ASD
(Hoeffer and Klann, 2010; Bhattacharya
et al., 2012). It is well known that acti-
vation of mTOR, when in a complex
with Raptor (mTORC1), stimulates cap-
dependent translation initiation and elon-
gation, thereby increasing protein syn-
thesis. Although excessive activation of
mTORC1 has been linked to increased
dendritic spine density and aberrant
behavior in mouse models of ASD (Santini
et al., 2013; Bhattacharya et al., 2012;
Tsai et al., 2012), the demonstration that
elevated mTORC1 signaling is correlated
with increased spine density late in brain
development in human ASD patients by
Tang et al. (2014) is novel. To further
dissect the precise mTORC1 effectors
that are responsible for the lack of devel-
opmental spine pruning in ASD, Tang
and colleagues focused on LC3-ii, a
marker of autophagosomes, and p62, an
autophagy protein substrate. LC3-ii was
decreased both in early and late develop-
ment in ASD patient brains, and p62 levels
were increased, suggesting that auto-
phagy is decreased in ASD both early
and late in development. Considering
that mTORC1 signaling negatively regu-
lates autophagy, Tang and colleagues
sought to further explore the mechanistic
relationship between elevated mTORC1
signaling, decreased autophagy, and
increased spine density in mouse models
of ASD. Toward this end, they utilized tu-
berous sclerosis complex 1 and 2 (Tsc1
and Tsc2) mutant mice, which are up-
stream negative regulators of mTORC1.
In humans, mutations that result in either
haploinsufficiency or reduced activity of
TSC1 and TSC2 lead to tuberous scle-sevier Inc.rosis complex (TSC), which has a high
incidence of ASD. In addition, mouse
models of TSC display ASD-like behav-
iors (Che´vere-Torres et al., 2012; Tsai
et al., 2012). Tang et al. (2014) found that
Tsc1 and Tsc2 mutant mice (Tsc1CKO
and Tsc2+/) had increased spine density
later in development. Moreover, Tsc2+/
mice exhibited increased mTORC1
signaling and reduced LC3-ii levels, sug-
gesting decreased autophagy, which
was correlated with impairments in novel
object recognition and social novelty
behavior. In addition, the dendritic spine
phenotypes in the TSC-deficient mice
were corrected with the mTORC1 inhibi-
tor rapamycin. These findings are consis-
tent with earlier reports that Tsc1 mutant
mice exhibit behavioral abnormalities
that can be rescued by rapamycin (Tsai
et al., 2012).
The role of autophagy in dendritic prun-
ing and ASD-like behaviors was further
examined by the authors in mice lacking
Atg7, which is essential for autophago-
some formation. Neuronal Atg7 condi-
tional knockout mice (Atg7CKO) displayed
deficits in pruning and behavioral aberra-
tions similar to the Tsc2+/ mice, but
these phenotypes were not fully rescued
by rapamycin. Moreover, when mouse
neurons in culture were treated with
Atg7siRNA at a ‘‘mature’’ developmental
stage, there was decreased synaptic
elimination, but not synapse formation,
further suggesting that autophagy is
required specifically for synapse elimina-
tion. These data are consistent with pre-
vious studies showing that stimulating
mTORC1 signaling increases spine for-
mation and density, which is sensitive to
disruption of mTORC1 and its effectors
involved in translation control (Bowling
Figure 1. Elevated mTORC1 Results in Reduced
Autophagy and Increased Spine Density in ASD
Individuals and Mouse Models
In control brains, there is a developmental decrease in
mTORC1 signaling that corresponds to balanced auto-
phagy (LC3-ii) and a decrease in spine number. In ASD
brains, there is no developmental decrease in mTORC1
signaling, and thus, there is a reduction in autophagy-
related markers. The disruption in mTORC1 signaling is
correlated with increased spine density at later develop-
mental stages, whereas control brains have undergone
synaptic pruning. This disruption of both mTORC1
signaling and autophagy in TSC model mice leads to
similar spine abnormalities and autistic-like behaviors.
Together, this model proposes a role for mTORC1 and
autophagy in the developmental pruning of dendritic
spines and that the disruption of this balance of may
contribute to the pathology of ASD.
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charya et al., 2012; Kumar et al.,
2005). Although elevated mTORC1
signaling may correspond with in-
creased spine turnover, the majority
of the data indicate that a long-term
reduction in mTORC1 signaling is
correlated with reduced spine density
(Jiang et al., 2013; Kumar et al., 2005).
Thus, activation of mTORC1 signaling
likely regulates dendritic spine forma-
tion and/or maintenance, and auto-
phagy likely regulates spine
elimination.
To further distinguish the contribu-
tion of the mTORC1 pathway to auto-
phagy from other cellular processes
in this context, the authors generated
Tsc2+/Atg7CKO double mutant mice.
The double mutant mice had reduced
dendritic pruning that was not
completely reversed by rapamycin, in
contrast to Tsc2+/ mice, which
showed improvement with rapamy-
cin. Similarly, Tsc2+/Atg7CKO double
mutant mice also exhibited impair-
ments in novel object recognition and
social behavior, which did not fully
respond to rapamycin treatment.
These results suggest that the rescue
of the improper dendritic pruning by
rapamycin is in part due to effects on
autophagyand that other downstream
effectors of mTORC1 contribute. In
addition, these data further support
the hypothesis that it is not solely dys-
regulated protein synthesis that
is responsible for mTORC1-depen-
dent increased spine density and
aberrant social behavior in ASD pa-
tients and ASD model mice. In
addition, previous reports suggest
TSC mutant model mice exhibit de-
creased protein synthesis (Auerbach
et al., 2011), which differs from other
ASD models where downstream
mTORC1 signaling is increased (San-
tini et al., 2013; Bhattacharya et al.,2012). This key divergence suggests that
in TSC, mTORC1-mediated regulation of
signaling pathways other than transla-
tional control are involved, as well as a
role for TSC1/2 in balancing mTORC1-
dependent autophagy. Thus, disruptions
in the TSC1/2-mTORC1 autophagy
pathway may be a point of convergence
in the heterogeneous ASD patient
population.Based on their findings, Tang and col-
leagues put forward two novel and very
important ideas. First, autophagy is crit-
ical to developmental dendritic spine
pruning, and second, both mTORC1
signaling and autophagy are disrupted
and do not undergo normal develop-
mental shifts in ASD brains (Figure 1).
These exciting findings raise additional
intriguing questions. Previous studiesNeuron 83, Septhave demonstrated that ASD model
mice with genetic mutations associ-
ated with mTORC1 signaling and
protein synthesis have disrupted syn-
aptic plasticity, particularly metabo-
tropic glutamate receptor-dependent
long-term depression (mGluR-LTD)
in the hippocampus (Che´vere-Torres
et al., 2012; Bhattacharya et al.,
2012; Santini et al., 2013; Bateup
et al., 2011; Auerbach et al., 2011).
However, in contrast to translation,
the role of autophagy in altered
mGluR-LTD has not been addressed.
In dopaminergic neurons, the deletion
of Atg7 results in decreased
neurotransmission (Hernandez et al.,
2012), consistent with the notion that
disruption of the mTORC1 and Atg7
pathways could impact synaptic
function. In contrast to the studies of
Tang et al., the bulk of the previous
studies were not performed in the
temporal cortex, which raises ques-
tions of how increased spine number,
reduced pruning, and decreased
autophagy alter the electrical signa-
ture of synapses and whether these
phenomena have regional specificity.
This is especially important given
that, in the hippocampus, Tsc1+/
mice had alterations in membrane ca-
pacitance and increased glutamater-
gic-related synaptic currents, despite
having no overall changes in spine
density (Bateup et al., 2011), suggest-
ing that there may be regional speci-
ficity in neuronal abnormalities in
TSC model mice. Another question
is the potential accumulation of pro-
teins and their identity, as other ASD
model mice have been shown to
have excessive protein synthesis
(Santini et al., 2013; Bhattacharya
et al., 2012). Finally, does reducing
autophagy, which is normally associ-
ated with the breakdown of proteins
and organelles, result in oversized ly-sosomes, increased accumulation of pro-
teins, and/or other cellular abnormalities
in ASD?
In summary, Tang et al. have reshaped
the landscape of ASD research focus by
introducing an mTORC1-dependent, but
potentially translation-independent, sig-
naling cascade that could underlie the
synaptic pruning deficits associated with
ASD. In addition, they demonstrated aember 3, 2014 ª2014 Elsevier Inc. 995
Neuron
Previewsnovel role for autophagy in developmental
dendritic spine pruning that provides
further insight into this carefully regulated
shaping of synaptic connections that
when dysregulated could contribute to
the behavioral deficits observed in ASD.
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Critical unmet clinical needs are the treatment of epilepsy without side effects and prevention of sudden un-
expected death in epilepsy, or SUDEP. In this issue ofNeuron, Qi et al. (2014), define how hyper-SUMOylation
impacts K+ channel activity in vivo and could serve as a potential pathway for development of novel epilepsy
therapeutics.The rate of sudden death in patients with
epilepsy is over 20 times higher than in
the general population (Shorvon and
Tomson, 2011). Sudden unexpected
death in epilepsy, or SUDEP, is the pri-
mary cause of mortality in patients with
epileptic disorders. Although SUDEP is
clearly linked to mutations in ion chan-
nels (Auerbach et al., 2013; Glasscock
et al., 2010; Goldman et al., 2009; Ka-
lume et al., 2013; Massey et al., 2014;
Surges and Sander, 2012), the specific
underlying pathophysiological mecha-
nism(s) remains elusive, and biomarkers
are not currently available. Thus, SUDEP
represents a major unmet clinical need
and a current focus of intense inves-tigation. Animal model and clinical
studies show that, in addition to neuronal
synchrony and hyperexcitability, respira-
tory and cardiovascular abnormalities
during and after seizures contribute to
SUDEP, suggesting important interac-
tions between brain and heart. In this
issue of Neuron, Qi et al. (2014) give
new perspective to the growing list of
potential SUDEP mechanisms, propos-
ing that genes within the ion channel
protein interactome may be pathogenic
candidates.
Looking beyond mutations in ion chan-
nels themselves, Qi and colleagues (Qi
et al., 2014) examine the in vivo role of
the dynamic processes of SUMOylationonneuronal excitability and its relationship
to SUDEP and seizures. SUMOylation, the
addition of ubiquitin-likeSUMO-modifying
groups to lysine residues, and subsequent
de-SUMOylation by Sentrin/SUMO-spe-
cific protease (SENPs), is known to alter
protein function and localization in multi-
ple tissues, including brain and heart
(Droescher et al., 2013; Wang, 2011). To
explore the role of SENP2 in SUMOylation
in vivo, Qi et al. generated a floxed SENP2
allele. Unexpectedly, the authors found
that SENPfxN/fxN mice, in which the
neomycin cassette was retained within
the floxed SENP2 allele, developed spon-
taneous convulsive seizures and died at
6–8 weeks with 100% penetrance.
